Financhill
Buy
66

CBWTF Quote, Financials, Valuation and Earnings

Last price:
$0.1100
Seasonality move :
7.62%
Day range:
$0.1012 - $0.1100
52-week range:
$0.0180 - $0.1357
Dividend yield:
0%
P/E ratio:
5.02x
P/S ratio:
1.53x
P/B ratio:
1.20x
Volume:
350.5K
Avg. volume:
777.7K
1-year change:
286.97%
Market cap:
$148.2M
Revenue:
$89.3M
EPS (TTM):
$0.02

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Auxly Cannabis Group, Inc. has -- downside to fair value with a price target of -- per share.

CBWTF vs. S&P 500

  • Over the past 5 trading days, Auxly Cannabis Group, Inc. has overperformed the S&P 500 by 0.61% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Auxly Cannabis Group, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Auxly Cannabis Group, Inc. has grown year-over-year revenues for 9 quarters straight. In the most recent quarter Auxly Cannabis Group, Inc. reported revenues of $29M.

Earnings Growth

  • Auxly Cannabis Group, Inc. has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Auxly Cannabis Group, Inc. reported earnings per share of $0.01.
Enterprise value:
173.3M
EV / Invested capital:
--
Price / LTM sales:
1.53x
EV / EBIT:
10.02x
EV / Revenue:
1.66x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
15.41x
Price / Operating cash flow:
14.25x
Enterprise value / EBITDA:
6.95x
Gross Profit (TTM):
$17.8M
Return On Assets:
17.11%
Net Income Margin (TTM):
31.08%
Return On Equity:
34.07%
Return On Invested Capital:
22.71%
Operating Margin:
-10.27%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $73.3M $84.2M $104.5M $24.4M $29M
Gross Profit -$3.9M $11.8M $17.8M $4.4M $6.4M
Operating Income -$33.8M -$17.8M -$15.1M -$2.8M -$3M
EBITDA -$24.3M -$9.9M -$7.4M -$892.2K -$965.6K
Diluted EPS -$0.01 -$0.06 $0.02 $0.00 $0.01
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $103.4M $74.1M $52.8M $56.9M $73.3M
Total Assets $310.6M $251.1M $225.5M $195.6M $198.7M
Current Liabilities $33.1M $64.8M $71M $66.7M $38M
Total Liabilities $130.6M $177.5M $152M $113.1M $74.7M
Total Equity $179.9M $73.6M $73.5M $82.5M $124M
Total Debt $91.2M $140.8M $115.6M $53M $47.4M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $4.5M $15.7M $13.2M $9.4M $7.3M
Cash From Investing -$4.3M -$256.5K -$1.9M -$471.4K -$1.2M
Cash From Financing -$5.7M -$7.3M -$3.5M -$5.2M $3.9M
Free Cash Flow $217K $13.7M $11.2M $8.9M $6.1M
CBWTF
Sector
Market Cap
$148.2M
$28.5M
Price % of 52-Week High
80.99%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
1%
-1.33%
1-Year Price Total Return
286.97%
-20.32%
Beta (5-Year)
1.350
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $0.1089
200-day SMA
Buy
Level $0.0851
Bollinger Bands (100)
Buy
Level 0.0975 - 0.1175
Chaikin Money Flow
Buy
Level 16.3M
20-day SMA
Sell
Level $0.1115
Relative Strength Index (RSI14)
Buy
Level 51.1334
ADX Line
Sell
Level 9.1987
Williams %R
Neutral
Level -39.738
50-day SMA
Buy
Level $0.1067
MACD (12, 26)
Sell
Level 0.0000
25-day Aroon Oscillator
Sell
Level -24
On Balance Volume
Sell
Level -217.2M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-2.4268)
Sell
CA Score (Annual)
Level (-1.4491)
Buy
Beneish M-Score (Annual)
Level (-3.0389)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (3.0187)
Buy
Piotroski F Score (Annual)
Level (8)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (4)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Auxly Cannabis Group, Inc. engages in developing, manufacturing, and distributing branded cannabis products for wellness and recreational consumers. It operates through the following segments: Canadian Cannabis Operations, Research Operations, and South American Cannabis Operations. The Canadian Cannabis Operations segment includes cultivation and sale of cannabis and cannabis 2.0 products within Canada. The Research Operations segment offers research services for customers who are conducting human clinical trials. The South American Cannabis Operations segment refers to cultivation of cannabis products through Inverell SA. The company was founded by Hugo M. Alves on August 24, 1987 and is headquartered in Toronto, Canada.

Stock Forecast FAQ

In the current month, CBWTF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CBWTF average analyst price target in the past 3 months is --.

  • Where Will Auxly Cannabis Group, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Auxly Cannabis Group, Inc. share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Auxly Cannabis Group, Inc.?

    Analysts are divided on their view about Auxly Cannabis Group, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Auxly Cannabis Group, Inc. is a Sell and believe this share price will rise from its current level to --.

  • What Is Auxly Cannabis Group, Inc.'s Price Target?

    The price target for Auxly Cannabis Group, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is CBWTF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Auxly Cannabis Group, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of CBWTF?

    You can purchase shares of Auxly Cannabis Group, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Auxly Cannabis Group, Inc. shares.

  • What Is The Auxly Cannabis Group, Inc. Share Price Today?

    Auxly Cannabis Group, Inc. was last trading at $0.1100 per share. This represents the most recent stock quote for Auxly Cannabis Group, Inc.. Yesterday, Auxly Cannabis Group, Inc. closed at $0.1099 per share.

  • How To Buy Auxly Cannabis Group, Inc. Stock Online?

    In order to purchase Auxly Cannabis Group, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock